Edwards Lifesciences Corp (NYSE:EW)
CAPS Rating:
A global provider of products and technologies designed to treat advanced cardiovascular disease. The Company focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies.
RSS Headlines
Fool UK
Recs
As the "bionic-being" lifestyle becomes more achieveable, EW will lead the way in "auto-heart" technology.